Evidence map›Paper›PMID 28029211›Full record

ArticleDiabetes/metabolism research and reviews2017

Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetes.

D R Webb, F Zaccardi, M J Davies, S J Griffin, N J Wareham, R K Simmons, G E Rutten, A Sandbaek, T Lauritzen, K Borch-Johnsen and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes/metabolism research and reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

D R WebbDiabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.
F ZaccardiDiabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.
M J DaviesDiabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.
S J GriffinMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
N J WarehamMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
R K SimmonsMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
G E RuttenJulius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, Netherlands.
A SandbaekSchool of Public Health, Section of General Practice, University of Aarhus, Aarhus, Denmark.
T LauritzenSchool of Public Health, Section of General Practice, University of Aarhus, Aarhus, Denmark.
K Borch-JohnsenHolbaek Hospital, Holbaek, Denmark.
K KhuntiDiabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.
Leicester General Hospital · GBAarhus University · DKUniversity of Cambridge · GBHolbæk Sygehus · DKMRC Epidemiology Unit · GBUniversity Medical Center Utrecht · NLUniversity of Leicester · GB

Funding

Department of Health 08/116/300Medical Research Council G0001164Medical Research Council MC_UU_12015/4Wellcome TrustWellcome Trust G061895
6 · The paper itself

Abstract

backgroundIt is unclear whether cardiovascular risk factor modification influences the development of renal disease in people with type 2 diabetes identified through screening. We determined predictors of albuminuria 5 years after a diagnosis of screen-detected diabetes within the ADDITION-Europe study, a pragmatic cardiovascular outcome trial of multifactorial cardiovascular risk management.

methodsIn 1826 participants with newly diagnosed, screen-detected diabetes without albuminuria, we explored associations between risk of new albuminuria (≥2.5 mg mmol

resultsAlbuminuria developed in 268 (15%) participants; baseline body mass index and active smoking were independently associated with new onset albuminuria in 5 years after detection of diabetes. In a model adjusted for age, gender, baseline HbA

conclusionsBaseline measurements and changes in HbA

Indexed as

AgedAlbuminuriaBlood PressureCardiovascular DiseasesDiabetes Mellitus, Type 2Diabetic NephropathiesFemaleGlycated HemoglobinHumansIncidenceMaleMiddle AgedRisk FactorsGlycated HemoglobinADDITION-Europealbuminuriamicrovascular complicationsscreeningsystolic blood pressuretype 2 diabetes

Identifiers

PMID28029211
PMCPMC6175057
OpenAlexW2573958410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.